Literature DB >> 21242517

Cutting Edge: Coding single nucleotide polymorphisms of endoplasmic reticulum aminopeptidase 1 can affect antigenic peptide generation in vitro by influencing basic enzymatic properties of the enzyme.

Irini Evnouchidou1, Ram P Kamal, Sergey S Seregin, Yoshikuni Goto, Masafumi Tsujimoto, Akira Hattori, Paraskevi V Voulgari, Alexandros A Drosos, Andrea Amalfitano, Ian A York, Efstratios Stratikos.   

Abstract

ER aminopeptidase 1 (ERAP1) customizes antigenic peptide precursors for MHC class I presentation and edits the antigenic peptide repertoire. Coding single nucleotide polymorphisms (SNPs) in ERAP1 were recently linked with predisposition to autoimmune disease, suggesting a link between pathogenesis of autoimmunity and ERAP1-mediated Ag processing. To investigate this possibility, we analyzed the effect that disease-linked SNPs have on Ag processing by ERAP1 in vitro. Michaelis-Menten analysis revealed that the presence of SNPs affects the Michaelis constant and turnover number of the enzyme. Strikingly, specific ERAP1 allele-substrate combinations deviate from standard Michaelis-Menten behavior, demonstrating substrate-inhibition kinetics; to our knowledge, this phenomenon has not been described for this enzyme. Cell-based Ag-presentation analysis was consistent with changes in the substrate inhibition constant K(i), further supporting that ERAP1 allelic composition may affect Ag processing in vivo. We propose that these phenomena should be taken into account when evaluating the possible link between Ag processing and autoimmunity.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21242517      PMCID: PMC4039038          DOI: 10.4049/jimmunol.1003337

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  18 in total

1.  26S proteasomes and immunoproteasomes produce mainly N-extended versions of an antigenic peptide.

Authors:  P Cascio; C Hilton; A F Kisselev; K L Rock; A L Goldberg
Journal:  EMBO J       Date:  2001-05-15       Impact factor: 11.598

Review 2.  Endoplasmic reticulum aminopeptidases: Biology and pathogenic potential.

Authors:  Nigil Haroon; Robert D Inman
Journal:  Nat Rev Rheumatol       Date:  2010-06-08       Impact factor: 20.543

3.  ERAAP customizes peptides for MHC class I molecules in the endoplasmic reticulum.

Authors:  Thomas Serwold; Federico Gonzalez; Jennifer Kim; Richard Jacob; Nilabh Shastri
Journal:  Nature       Date:  2002-10-03       Impact factor: 49.962

Review 4.  The biological significance of substrate inhibition: a mechanism with diverse functions.

Authors:  Michael C Reed; Anna Lieb; H Frederik Nijhout
Journal:  Bioessays       Date:  2010-05       Impact factor: 4.345

5.  Serum cytokine receptors in ankylosing spondylitis: relationship to inflammatory markers and endoplasmic reticulum aminopeptidase polymorphisms.

Authors:  Nigil Haroon; Florence W L Tsui; Basil Chiu; Hing Wo Tsui; Robert D Inman
Journal:  J Rheumatol       Date:  2010-07-01       Impact factor: 4.666

6.  The ER aminopeptidase, ERAP1, trims precursors to lengths of MHC class I peptides by a "molecular ruler" mechanism.

Authors:  Shih-Chung Chang; Frank Momburg; Nidhi Bhutani; Alfred L Goldberg
Journal:  Proc Natl Acad Sci U S A       Date:  2005-11-14       Impact factor: 11.205

7.  The ER aminopeptidase ERAP1 enhances or limits antigen presentation by trimming epitopes to 8-9 residues.

Authors:  Ian A York; Shih-Chung Chang; Tomo Saric; Jennifer A Keys; Janice M Favreau; Alfred L Goldberg; Kenneth L Rock
Journal:  Nat Immunol       Date:  2002-11-18       Impact factor: 25.606

8.  An IFN-gamma-induced aminopeptidase in the ER, ERAP1, trims precursors to MHC class I-presented peptides.

Authors:  Tomo Saric; Shih-Chung Chang; Akira Hattori; Ian A York; Shirley Markant; Kenneth L Rock; Masafumi Tsujimoto; Alfred L Goldberg
Journal:  Nat Immunol       Date:  2002-11-18       Impact factor: 25.606

9.  Identification of ARTS-1 as a novel TNFR1-binding protein that promotes TNFR1 ectodomain shedding.

Authors:  Xinle Cui; Feras Hawari; Sura Alsaaty; Marion Lawrence; Christian A Combs; Weidong Geng; Farshid N Rouhani; Dianne Miskinis; Stewart J Levine
Journal:  J Clin Invest       Date:  2002-08       Impact factor: 14.808

10.  Genome-wide association study of ankylosing spondylitis identifies non-MHC susceptibility loci.

Authors:  John D Reveille; Anne-Marie Sims; Patrick Danoy; David M Evans; Paul Leo; Jennifer J Pointon; Rui Jin; Xiaodong Zhou; Linda A Bradbury; Louise H Appleton; John C Davis; Laura Diekman; Tracey Doan; Alison Dowling; Ran Duan; Emma L Duncan; Claire Farrar; Johanna Hadler; David Harvey; Tugce Karaderi; Rebecca Mogg; Emma Pomeroy; Karena Pryce; Jacqueline Taylor; Laurie Savage; Panos Deloukas; Vasudev Kumanduri; Leena Peltonen; Sue M Ring; Pamela Whittaker; Evgeny Glazov; Gethin P Thomas; Walter P Maksymowych; Robert D Inman; Michael M Ward; Millicent A Stone; Michael H Weisman; B Paul Wordsworth; Matthew A Brown
Journal:  Nat Genet       Date:  2010-01-10       Impact factor: 38.330

View more
  65 in total

1.  Endoplasmic reticulum aminopeptidase-1 alleles associated with increased risk of ankylosing spondylitis reduce HLA-B27 mediated presentation of multiple antigens.

Authors:  Sergey S Seregin; David P W Rastall; Irini Evnouchidou; Charles F Aylsworth; Dionisia Quiroga; Ram P Kamal; Sarah Godbehere-Roosa; Christopher F Blum; Ian A York; Efstratios Stratikos; Andrea Amalfitano
Journal:  Autoimmunity       Date:  2013-09-13       Impact factor: 2.815

2.  Editing the immunopeptidome of melanoma cells using a potent inhibitor of endoplasmic reticulum aminopeptidase 1 (ERAP1).

Authors:  Despoina Koumantou; Eilon Barnea; Adrian Martin-Esteban; Zachary Maben; Athanasios Papakyriakou; Anastasia Mpakali; Paraskevi Kokkala; Harris Pratsinis; Dimitris Georgiadis; Lawrence J Stern; Arie Admon; Efstratios Stratikos
Journal:  Cancer Immunol Immunother       Date:  2019-06-20       Impact factor: 6.968

Review 3.  Genetics and the Causes of Ankylosing Spondylitis.

Authors:  Aimee Hanson; Matthew A Brown
Journal:  Rheum Dis Clin North Am       Date:  2017-08       Impact factor: 2.670

4.  Manipulation of EAT-2 expression promotes induction of multiple beneficial regulatory and effector functions of the human innate immune system as a novel immunomodulatory strategy.

Authors:  Yasser A Aldhamen; Sergey S Seregin; Charles F Aylsworth; Sarah Godbehere; Andrea Amalfitano
Journal:  Int Immunol       Date:  2013-12-27       Impact factor: 4.823

Review 5.  Endoplasmic reticulum aminopeptidase 1 and rheumatic disease: functional variation.

Authors:  Tri M Tran; Robert A Colbert
Journal:  Curr Opin Rheumatol       Date:  2015-07       Impact factor: 5.006

6.  Redundancy and Complementarity between ERAP1 and ERAP2 Revealed by their Effects on the Behcet's Disease-associated HLA-B*51 Peptidome.

Authors:  Pablo Guasp; Elena Lorente; Adrian Martín-Esteban; Eilon Barnea; Paolo Romania; Doriana Fruci; JonasJ W Kuiper; Arie Admon; José A López de Castro
Journal:  Mol Cell Proteomics       Date:  2019-05-15       Impact factor: 5.911

Review 7.  Pathogenesis of ankylosing spondylitis - recent advances and future directions.

Authors:  Vidya Ranganathan; Eric Gracey; Matthew A Brown; Robert D Inman; Nigil Haroon
Journal:  Nat Rev Rheumatol       Date:  2017-04-27       Impact factor: 20.543

8.  Both rare and common ERAP1 allotypes have distinct functionality defined by polymorphic context and are important in AS association.

Authors:  Emma Reeves; Tim Elliott; Christopher J Edwards; Edward James
Journal:  Proc Natl Acad Sci U S A       Date:  2017-02-22       Impact factor: 11.205

9.  Structural Basis for Antigenic Peptide Recognition and Processing by Endoplasmic Reticulum (ER) Aminopeptidase 2.

Authors:  Anastasia Mpakali; Petros Giastas; Nikolas Mathioudakis; Irene M Mavridis; Emmanuel Saridakis; Efstratios Stratikos
Journal:  J Biol Chem       Date:  2015-09-17       Impact factor: 5.157

Review 10.  Monitoring peptide processing for MHC class I molecules in the endoplasmic reticulum.

Authors:  Nilabh Shastri; Niranjana Nagarajan; Kristin C Lind; Takayuki Kanaseki
Journal:  Curr Opin Immunol       Date:  2013-12-11       Impact factor: 7.486

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.